
[Federal Register Volume 76, Number 202 (Wednesday, October 19, 2011)]
[Notices]
[Pages 64949-64950]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27019]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0494]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Data To Support 
Communications To Educate Consumers on How To Safely Purchase Drugs 
Online

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by 
November 18, 2011.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
Fax: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All 
comments should be identified with the OMB control number 0910-NEW and 
title ``Data to Support Communications to Educate Consumers on How to 
Safely Purchase Drugs Online.'' Also include the FDA docket number 
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-7651, 
Juanmanuel.vilela@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Data To Support Communications To Educate Consumers on How To Safely 
Purchase Drugs Online--(OMB Control Number 0910-NEW)

    FDA has planned an integrated public outreach campaign to improve 
the safe use of online pharmacies for drug purchases. In order to 
effectively evaluate this campaign, FDA must understand individuals' 
knowledge, attitudes, and practices with regard to online pharmacies 
both at the start of the campaign and on an ongoing basis. This will 
enable FDA to gauge progress toward educating the public on safely 
purchasing from online pharmacies. An online survey panel will be 
employed to collect this information, which serves the need for direct 
and quantitative measurement of our target population, and which, as a 
quantitative research tool has some major benefits:
     To focus on our target population of adults who use the 
Internet.
     To collect data quickly and efficiently with minimal cost 
to the government.
     To reduce burden to the public by providing a means to 
complete the survey at a time and place of their choosing.
    FDA will use online data collection to establish a baseline and 
evaluate the success of its messages and distribution methods for its 
outreach campaign, which educates consumers about how to safely 
purchase drugs online. Additionally, FDA will use this method to help 
tailor messages and communications vehicles to have both a more 
powerful and desired impact on target audiences. The data will not be 
used for the purposes of making policy or regulatory decisions.
    In the Federal Register of July 12, 2011 (76 FR 40920), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. FDA received no comments.
    FDA estimates the burden of this collection of information as 
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                      Number of
                            Activity                                 Number of      responses per     Total annual   Average burden per    Total hours
                                                                    respondents       respondent       responses          response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Survey Study....................................................           5,000                1            5,000       .33 (20 min.)            1,650
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.


[[Page 64950]]

    Annually, FDA projects one survey study. FDA is requesting this 
data collection burden so as not to restrict the Agency's ability to 
gather information on public sentiment for its proposals in its 
regulatory and communications programs.

    Dated: October 14, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-27019 Filed 10-18-11; 8:45 am]
BILLING CODE 4160-01-P


